DotBio logo

DotBio jobs and careers

About DotBio

DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.

Founded in 2017 by Ignacio Nacho Asial.

Founded
2017
Employees
1 to 10
Total funding
$8.1M